Supreme Cannabis Co Inc fka SPRWF

[sillylung]

Management update 3/26/2014
Very exciting!

To all of our shareholders, followers, and stakeholders, we welcome you to the community at Supreme Pharmaceuticals. We are excited to publish our first of many to come "Management Updates" in an effort to interact with you.

Many of you have noticed the recent halt on the stock and have expressed either concern or excitement. So what does this mean for the company?

At Supreme, we want you to know that management is not concerned about the brief halt that the company experienced. In the long-term we believe it will have little bearing on us and certainly will not hinder the future development of the company or it’s current ventures.

We have had an intense and news-filled past few days; we are happy that you have been able to share them with us. Medical Marijuana, in conjunction with our pursuit of medical devices, has brought a wealth of new attention to the company that we are excited about.

The company has been the largest traded stock in terms of volume on the Toronto Stock Venture Exchange (TSX.V) multiple times recently, and was once again yesterday as per this link to Stockhouse: http://www.stockhouse.com/markets/stocks/tsxv (link will expire at the end of the trading day Wednesday March 26th, 2014). We believe this is extremely positive news for us.

To our investors and stakeholders: We thank you for your continued support. As always we will aggressively pursue opportunities that provide long-term shareholder value. Currently, that means securing a medical device, completing the due diligence on our current purchase option agreement for a producing medical marijuana facility, and applying for a MMPR commercial licence. We believe these ventures will bring the most value to our company.

If you have any questions or would like to speak with us please reach out, as we would like to hear from all of you.

To the future of Supreme and many more Management Updates,

Management

Contact info is attached in header.

Note: This is not a news release and should not be treated as such; it is for the purpose of engaging with our community.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

http://www.supremepharmaceuticals.com/index.php/corporate/management-updates/21-management-update-march-26th-2014